Shaji Kumar - Mayo Clinic | 人才画像

基本信息

Career Trajectory

Bio

Shaji Kumar, MD is a consultant in the Division of Hematology at Mayo Clinic, and Professor of Medicine in the College of Medicine, Mayo Clinic, Rochester, MN. He is currently the Medical Director for the Cancer Center Clinical Trials Office. He also serves as the co-chair of the NCI Myeloma Steering Committee.

Research Interests

Papers共 19 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A fourth category of VGKC positive patients: A retrospective study from a south Indian population

R. Ramesh,P. Hazeena,S. Shanmugam,S. Venkatasubramanium

EUROPEAN JOURNAL OF NEUROLOGY（2020）

Cited0Views0Bibtex

An epidemic of sub acute intestinal obstruction during Covid‐19 pandemic related lockdown ‐ ‘the lockdown belly’

S Philip,A David,K S Kumar, R J Renny,V Pillai, S R Manda

BRITISH JOURNAL OF SURGERY（2020）

Cited1Views0WOSBibtex

Progressive supra nuclear palsy phenotype with idiopathic basal ganglia calcification

R. Ramesh, V. Paramanandham,S. Venkatasubramanian,S. Shanmugam

MOVEMENT DISORDERS（2020）

Cited0Views0Bibtex

Correlation Between The Presence And Type Of Dehydration At Stroke Onset, With Stroke Severity And Large Vessel Occlusion: A Prospective Study From A Tropical Country

R. Ramesh,P. Hazeena,S. Shanmugam,V. Shankar,S. Venkatasubramanium

INTERNATIONAL JOURNAL OF STROKE（2020）

Cited0Views0Bibtex

Prevalence of Dehydration at acute ischemic stroke onset and correlation between stroke severity and dehydration sub-type: A prospective study from a tropical country

R. Ramesh,P. Hazeena,V. Shankar,S. Shanmugam,S. Venkatasubramanium

EUROPEAN JOURNAL OF NEUROLOGY（2020）

Cited0Views0Bibtex

Mayo Clinic Strategies for COVID 19 Rapid Appraisal System for COVID 19 Medical Information

Raymund R. Razonable,William F. Marshall,Ryan W. Stevens,Shaji Kumar,M. Hassan Murad,Walter R. Wilson

Mayo Clinic Proceedings (2020)

Cited0Views0Bibtex

A Phase 1 First-in-Human Study of the Anti-CD38 Dimeric Fusion Protein TAK-169 for the Treatment of Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) Who Are Proteasome Inhibitor (PI)- and Immunomodulatory Drug (Imid)-Refractory, Including Pts Relapsed/Refractory (R/R) or Naïve to Daratumumab (Dara)

Shaji K. Kumar, Robert F. Cornell,Ola Landgren,Sikander Ailawadhi,Jack P. Higgins,Erin K. Willert,Roger Waltzman,Jianchang Lin, Yuhong Zhang, Anya R. Lublinsky,Ajeeta B. Dash,Michael Hanley, Divya Manoharan, Morgan Leichter,Sean Ottinger,Richard J. Labotka,John Newcomb,Alexander Vorog

BLOOD（2019）

Cited5Views0Bibtex

EARLY HEMODYNAMIC CHANGES OF TILT TABLE TESTING PREDICTS NEUROCARDIOGENIC RESPONSE IN AFRICAN AMERICAN POPULATION

D. Ho, M. Ghods,S. Kumar, N. Warrier,H. Ilias Basha,J. Kassotis

CARDIOLOGY（2015）

Cited0Views0Bibtex

Identification of structurally permissive regions in coagulation factor VIII suitable for the insertion of exogenous peptidyl elements

K. John,T. Liu, P-Y B. Chang,S. Ding,S. Patarroyo-White,A. Goodman,S. Kumar, D. Wang,Seth E. Chhabra,A. Mezo, J. R. Pierce,J. Haiyan, M. Baisong,V Schellenberger, P. Robert

JOURNAL OF THROMBOSIS AND HAEMOSTASIS（2013）

Cited0Views0Bibtex

A combinatorial library approach to generate rFVIII variants with multiple XTEN insertions and improved pharmacokinetic properties

T. Liu,J. Kulman, P-Yb Chang,S. Patarroyo-White,D. Drager, S. Ding,E. S. Chhabra,S. Kumar,B. Pape,N. Moore,S. Bardan,A. Goodman,M. Acosta,G. F. Pierce,V Schellenberger,B. Mei, R. T. Peters,H. Jiang

JOURNAL OF THROMBOSIS AND HAEMOSTASIS（2013）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn